The TruCheck test does not detect all cancer types and not all cancer types can be detected in the blood. False negative and false positive results do occur.


Only 5 recommended cancer screening tests exist today2:
breast, colorectal, lung (for those at risk), cervical, and prostate

About 3 out of 4 new cancer cases and cancer-related deaths
will be due to cancers with no recommended screening.5
The TruCheck test looks for signals related to active cancer and does not predict your future genetic predisposition for cancer.
TruCheck is a pioneering multi-cancer early detection test—a test that identifies signals associated with a broad range of cancer types using a single blood sample. It operates as a screening tool and does not diagnose cancer; further diagnostic testing is essential for cancer confirmation.

⦁ You are aged 40 or over
⦁ You have no prior history of diagnosis or treatment of any type of cancer
⦁ You are not displaying any symptoms of cancer at this time
⦁ You have no clinical suspicion of cancer at this time
⦁ You have not had a blood transfusion in the past 72 hours
⦁ You consent to having a sample of your blood taken from you by a trained professional
The TruCheck test is for adults aged 40 or over (35–39 if at higher risk, on enquiry) who have no symptoms of cancer. TruCheck does not detect all types of cancers and should be considered a supplemental tool alongside routine cancer screening tests advised by your healthcare provider. The primary goal of TruCheck is to identify cancer signals and predict their origin within the body. It is not recommended for use in individuals who are pregnant or currently undergoing active cancer treatment.
Results must be analysed by a healthcare professional, taking into account the patient’s medical history, clinical signs, and symptoms. A result of “No Cancer Signal Detected” does not definitively exclude the presence of cancer. Likewise, a “Cancer Signal Detected” result necessitates further diagnostic evaluation through established medical procedures (such as imaging) to confirm the presence of cancer.
In cases where further testing does not confirm cancer, this could indicate either the absence of cancer or that the test was unable to detect it, including situations where the cancer is located in a different part of the body. Be aware that false-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) results can occur.
1. Akolkar et al. B15: Circulating tumor cells express tissue specific antigens in multiple cancers. Clin Cancer Res.2020;
26(11_Suppl). DOI: 10.1158/1557-3265.LiqBiop20-B15.
2. Akolkar et al. Circulating ensembles of tumor-associated cells: A redoubtable new systemic hallmark of cancer. Int. J.
Cancer:2019; 146, 3485-3494. DOI: 10.1002/ijc.32815.
3. Gaya A et al. Evaluation of circulating tumor cell clusters for pan-cancer noninvasive diagnostic triaging. Cancer Cytopathol.
2020; 129 (3) 226-238 doi: 10.1002/cncy.22366.
4. Ranade A et al. Hallmark Circulating Tumor-Associated Cell Clusters Signify 230 Times Higher One-Year Cancer Risk. Cancer
Prev Res. 2021;14:11-6 DOI:10.1158/1940-6207.CAPR-20-0322.
5. Crook T et al. Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells. Cancers
(Basel). 2022 Jul; 14(14): 3341. DOI: 10.3390/cancers14143341.